In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Christopher Reid
Christopher Reid
Christopher Reid Christopher Reid

Curtin University, Melbourne (Australia)

Specialities : Risk Factors and Prevention , Hypertension, Public Health and Health Economics, Chronic Heart Failure, Research Methodology

Christopher Reid is a cardiovascular epidemiologist with appointments as Research Professor in both the School of Public Health at Curtin University and the School of Public Health and Preventive Medicine, Monash University. He was appointed as a John Curtin Distinguished Professor in 2018 and is Director of the Monash and Curtin Centre’s of Cardiovascular Research and Education (CCRE) and the NHMRC Centre of Research Excellence in Cardiovascular Outcomes Improvement (2016-2020). He holds a National Health and Medical Research Council Principal Research Fellowship (2018-2022) in addition to being the Chief Investigator on an NHMRC Program Grant (2016-2020) focusing on cardiovascular disease prevention.

2 presentations from this speaker

A risk based approach to the role of aspirin on cardiovascular risk reduction in a healthy older cohort

Event : ESC Congress 2019

  • Session : Late Breaking Science in Cardiovascular Pharmacology
  • Speaker : C Reid (Perth,AU)

The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) Registry.

Event : ESC Congress 2019

  • Session : Why should registry data impact clinical practice?
  • Speaker : C Reid (Perth,AU)
  • Joint with the Asian Pacific Society of Cardiology

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are